PAREXEL Expands Regional Distribution Center and Supply Depot Network to Enhance Global Clinical Logistics Services
PAREXEL International Corporation, a leading global biopharmaceutical services provider, has announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company’s facilities in Billerica, Mass., will help PAREXEL more effectively manage clients’ global clinical trial supply requirements.
PAREXEL’s Clinical Logistics Services provides synchronized coordination of clinical trial supplies, central lab services, and ancillary supplies worldwide to ensure safe and timely distribution. The Company offers risk evaluation and mitigation planning for in-time-investigational-site supply, as well as expertise in global import/export compliance. New capabilities include secondary packaging and labeling services. The facility expansion builds upon PAREXEL’s considerable global clinical logistics infrastructure in North America, Latin America, Europe, Africa and the Asia/Pacific region.
“As clinical trials increase in size and complexity, clients are challenged to develop and implement strategies that create consistent sourcing, manufacturing, storage and distribution processes along the supply chain,” said Mark A. Goldberg, President and Chief Operating Officer, PAREXEL. “Our investments in these important distribution centers and depots are part of the company’s ongoing efforts to simplify the clinical trial journey for biopharmaceutical clients by supporting their growing global supply and logistics needs.”
PAREXEL’s clinical logistics facilities offer sophisticated capabilities that include enhanced expiry and update labeling services. These services eliminate the need to return supplies to the manufacturing organization, reduce study start-up time and help ensure timely first-patient-in milestones. Additional capabilities include a distribution and warehousing infrastructure to manage and transport clinical trial supplies to locations worldwide, as well as leading technology systems that track and trace shipments and manage inventory levels.
“PAREXEL continues to build a global network of storage and distribution facilities with harmonized configurations that provide a consistent and reliable flow of materials needed in the clinical trial process,” said Kurt Norris, Corporate Vice President, Clinical Logistics Services, PAREXEL. “This reflects our commitment to provide leading-edge management of clinical trial materials to clients across the globe.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance